Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高级检索
  • Immune monitoring in cancer im...
  • 引用
  • 发送短信
  • 推荐此
  • 打印
  • 导出纪录
    • 导出到 RefWorks
    • 导出到 EndNoteWeb
    • 导出到 EndNote
  • Permanent link
Immune monitoring in cancer immunotherapy.

Immune monitoring in cancer immunotherapy.

书目详细资料
Main Authors: Romero, P, Pittet, M, Valmori, D, Speiser, D, Cerundolo, V, Liénard, D, Lejeune, F, Cerottini, J
格式: Journal article
语言:English
出版: 2000
  • 持有资料
  • 实物特征
  • 相似书籍
  • 职员浏览

相似书籍

  • High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
    由: Pittet, M, et al.
    出版: (1999)
  • An antigen-targeted approach to adoptive transfer therapy of cancer.
    由: Valmori, D, et al.
    出版: (1999)
  • CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
    由: Speiser, D, et al.
    出版: (1999)
  • Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
    由: Valmori, D, et al.
    出版: (2000)
  • Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
    由: Valmori, D, et al.
    出版: (1999)

检索选项

  • 检索历史
  • 高级检索

查找更多

  • 浏览目录
  • 按字母顺序浏览
  • 探索频道
  • 课程储备
  • 新项目

需要帮助?

  • 检索技巧
  • 咨询台
  • 常见问题